ANI PHARMACEUTICALS INC (ANIP) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0001023024 · SEC filings checked Oct 17, 2026

    Next report
    Nov 23, 2026
    Estimated from reporting history (107-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
    Last close
    $72.29
    Polygon.io daily close, Oct 16, 2026. End of day, not live.
    Trailing diluted EPS
    $4.60
    Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025 · P/E 15.7

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Jun 30, 2026Aug 7, 2026$266.0M$24.7M$1.05Filing
    Mar 31, 2026May 8, 2026$237.5M$29.5M$1.28Filing
    Dec 31, 2025Jan 12, 2026$247.1M$27.2M$1.14Filing
    Sep 30, 2025Nov 7, 2025$227.8M$26.6M$1.13Filing
    Jun 30, 2025Jul 23, 2025$211.4M$8.5M$0.36Filing
    Mar 31, 2025May 9, 2025$197.1M$15.7M$0.69Filing
    Dec 31, 2024Jan 13, 2025$190.6M$-10.8M$-0.45Filing
    Sep 30, 2024Nov 8, 2024$148.3M$-24.2M$-1.27Filing

    What would ANI PHARMACEUTICALS INC have to report for its valuation to change?

    At $72.29, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 6.1% a year, to $6.18. On that path the next quarter needs diluted EPS near $1.20, against $1.13 in the quarter ended Sep 30, 2025.

    Are you considering buying, or do you already own shares?

    Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.

    ResultOriginalYours
    Required EPS growth / year6.1%6.1%
    EPS needed in final year$6.18$6.18

    Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.

    Prepare for earnings across my investments — $399/month

    Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. ANIP goes in with your buy-or-wait comparison and assumptions preserved.

    Start Desk — $399/month

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.